NDC 67046-1477-03 - Dapsone
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67046-1477
- Requested NDC
- 67046-1477-03
- Package NDCs from labels
- 67046-1477-3, 67046-1477-03
- Manufacturer
- Coupler LLC
- Effective date
- 2025-01-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Dapsone - Coupler LLC | Coupler LLC | 2025-01-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67046-1477-3 | Dapsone | 30 in 1 BLISTER PACK | TABLET | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 67046-1477 | DAPSONE TABLET [COUPLER LLC] | 1 | Current NDC, 1 package rows | 20250201_2d018cbb-21b2-5f63-e063-6394a90aadc3.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dapsone | DAPSONE | Macleods Pharmaceuticals Limited | 839d7440-ba0e-4c56-b648-d374b155cf03 | 2026-07-20 | Warnings, Adverse reactions | 197557 197558 8W5C518302 |
| DAPSONE | DAPSONE | Alembic Pharmaceuticals Limited | 0f1301f6-884d-4fc7-a5b2-421b2375b985 | 2026-07-09 | Warnings, Adverse reactions | 8W5C518302 |
| DAPSONE | DAPSONE | Alembic Pharmaceuticals Inc. | 7249f655-1d8e-482a-889a-1e7e1a19500c | 2026-07-09 | Warnings, Adverse reactions | 8W5C518302 |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| Dapsone 25mg | DAPSONE 25MG | Solis Pharmaceuticals Inc. | 50204029-4c29-5b8d-e063-6394a90af383 | 2026-04-17 | Warnings, Adverse reactions | 197557 197558 8W5C518302 |
| Dapsone | DAPSONE | Sun Pharmaceutical Industries, Inc. | cb312185-b9f1-4fa4-9481-bcf5d9bb3edf | 2026-03-17 | Warnings, Adverse reactions | 197557 197558 8W5C518302 |
| Dapsone | DAPSONE | Viona Pharmaceuticals Inc | 58e7b363-99fb-4225-8df1-db2114d74928 | 2026-02-27 | Warnings, Adverse reactions | 197557 197558 8W5C518302 |
| Dapsone | DAPSONE | Zydus Lifesciences Limited | 1d6bc112-ba2f-40ab-975d-9cfbc853cd11 | 2026-02-27 | 197557 197558 8W5C518302 | |
| Dapsone | DAPSONE | Rising Pharma Holdings, Inc. | e369b26d-219a-4e23-b8d4-f94048d36acd | 2026-01-28 | Warnings, Adverse reactions | ANDA207165 64980-566 197557 197558 e1aaf1ed-de8a-4c31-85de-68d728c95e86 e369b26d-219a-4e23-b8d4-f94048d36acd 8W5C518302 |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Dapsone | DAPSONE | AvKARE | 13002250-b4c5-5890-e063-6394a90a2036 | 2026-01-13 | Warnings, Adverse reactions | 197558 8W5C518302 |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| Dapsone | DAPSONE | AvKARE | 459c00e0-2124-8965-e063-6294a90a4278 | 2025-12-10 | Warnings, Adverse reactions | 197558 8W5C518302 |
| Dapsone | DAPSONE GEL, 5% | Encube Ethicals, Inc. | 4205a1a9-c459-47bb-9538-1dd559ca71f1 | 2025-10-31 | Warnings, Adverse reactions | 8W5C518302 |
| Aczone | DAPSONE | Almirall, LLC | 22058b7d-a578-4eaa-a476-ac982337f02a | 2025-10-23 | Warnings, Adverse reactions | 8W5C518302 |
| Dapsone | DAPSONE | Alembic Pharmaceuticals Limited | d71eba65-3d78-4252-acb8-90eea60921d1 | 2025-09-25 | Warnings, Adverse reactions | 8W5C518302 |
| Dapsone | DAPSONE GEL, 5% | Trupharma, LLC | 699b6157-3245-43b6-91ee-c86ea262bc83 | 2025-09-05 | Warnings, Adverse reactions | 8W5C518302 |
| Dapsone | DAPSONE | Trupharma, LLC | 2763bcbb-e249-be2b-e063-6394a90a5015 | 2025-09-05 | Warnings, Adverse reactions | 8W5C518302 |
| TRIMO SAN | OXYQUINOLINE SULFATE AND SODIUM LAURYL SULFATE | CooperSurgical, Inc. | 1e4a1caa-e6ba-44ef-8347-07e6385a7c9e | 2025-09-03 | Warnings | 368GB5141J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.